Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Exome sequence analysis of Finnish patients with clozapine-induced agranulocytosis.

Tiwari AK, Need AC, Lohoff FW, Zai CC, Chowdhury NI, Müller DJ, Putkonen A, Repo-Tiihonen E, Hallikainen T, Yağcıoğlu AE, Tiihonen J, Kennedy JL, Meltzer HY.

Mol Psychiatry. 2014 Apr;19(4):403-5. doi: 10.1038/mp.2013.74. Epub 2013 Jun 11. No abstract available.

PMID:
23752246
2.

Clozapine rechallenge after excluding the high-risk clozapine-induced agranulocytosis genotype of HLA-DQB1 6672G>C.

McKnight C, Guirgis H, Votolato N.

Am J Psychiatry. 2011 Oct;168(10):1120. doi: 10.1176/appi.ajp.2011.11020202. No abstract available.

PMID:
21969051
3.

Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles.

Goldstein JI, Jarskog LF, Hilliard C, Alfirevic A, Duncan L, Fourches D, Huang H, Lek M, Neale BM, Ripke S, Shianna K, Szatkiewicz JP, Tropsha A, van den Oord EJ, Cascorbi I, Dettling M, Gazit E, Goff DC, Holden AL, Kelly DL, Malhotra AK, Nielsen J, Pirmohamed M, Rujescu D, Werge T, Levy DL, Josiassen RC, Kennedy JL, Lieberman JA, Daly MJ, Sullivan PF.

Nat Commun. 2014 Sep 4;5:4757. doi: 10.1038/ncomms5757.

4.

Candidate gene analysis identifies a polymorphism in HLA-DQB1 associated with clozapine-induced agranulocytosis.

Athanasiou MC, Dettling M, Cascorbi I, Mosyagin I, Salisbury BA, Pierz KA, Zou W, Whalen H, Malhotra AK, Lencz T, Gerson SL, Kane JM, Reed CR.

J Clin Psychiatry. 2011 Apr;72(4):458-63. doi: 10.4088/JCP.09m05527yel. Epub 2010 Sep 21.

PMID:
20868635
5.

Establishing the characteristics of an effective pharmacogenetic test for clozapine-induced agranulocytosis.

Verbelen M, Collier DA, Cohen D, MacCabe JH, Lewis CM.

Pharmacogenomics J. 2015 Oct;15(5):461-6. doi: 10.1038/tpj.2015.5. Epub 2015 Mar 3.

6.

Mitchell B. Balter Award. Human leukocyte antigen-A1 predicts a good therapeutic response to clozapine with a low risk of agranulocytosis in patients with schizophrenia.

Lahdelma L, Ahokas A, Andersson LC, Suvisaari J, Hovatta I, Huttunen MO, Koskimies S.

J Clin Psychopharmacol. 2001 Feb;21(1):4-7.

PMID:
11199946
7.

Psychopharmacology. Clozapine and agranulocytosis.

Feldman J.

Psychiatr Serv. 1996 Nov;47(11):1177-8. No abstract available.

PMID:
8916231
8.

[Patient knowledge regarding Clozapine-induced agranulocytosis].

Haberfellner EM, Rittmannsberger H.

Psychiatr Prax. 2006 May;33(4):194-6. German. No abstract available.

PMID:
16680627
9.

HLA-B38 and clozapine-induced agranulocytosis in Israeli Jewish schizophrenic patients.

Valevski A, Klein T, Gazit E, Meged S, Stein D, Elizur A, Narinsky ER, Kutzuk D, Weizman A.

Eur J Immunogenet. 1998 Feb;25(1):11-3.

PMID:
9587740
10.

How close are we to a pharmacogenomic test for clozapine-induced agranulocytosis?

Verbelen M, Lewis CM.

Pharmacogenomics. 2015;16(9):915-7. doi: 10.2217/pgs.15.67. Epub 2015 Jun 30. No abstract available.

11.

Further evidence of human leukocyte antigen-encoded susceptibility to clozapine-induced agranulocytosis independent of ancestry.

Dettling M, Schaub RT, Mueller-Oerlinghausen B, Roots I, Cascorbi I.

Pharmacogenetics. 2001 Mar;11(2):135-41.

PMID:
11266078
12.

Clozapine-induced agranulocytosis and its genetic determinants.

Opgen-Rhein C, Dettling M.

Pharmacogenomics. 2008 Aug;9(8):1101-11. doi: 10.2217/14622416.9.8.1101. Review.

PMID:
18681784
13.

Clozapine-induced agranulocytosis in schizophrenic Caucasians: confirming clues for associations with human leukocyte class I and II antigens.

Dettling M, Cascorbi I, Opgen-Rhein C, Schaub R.

Pharmacogenomics J. 2007 Oct;7(5):325-32. Epub 2006 Oct 17.

PMID:
17001352
14.

[Clozapine-induced agranulocytosis: genetic risk factors and an immunologic explanatory model].

Güzelcan Y, Scholte WF.

Tijdschr Psychiatr. 2006;48(4):295-302. Review. Dutch.

15.

Clozapine-induced agranulocytosis and hereditary polymorphisms of clozapine metabolizing enzymes: no association with myeloperoxidase and cytochrome P4502D6.

Dettling M, Sachse C, Müller-Oerlinghausen B, Roots I, Brockmöller J, Rolfs A, Cascorbi I.

Pharmacopsychiatry. 2000 Nov;33(6):218-20.

PMID:
11147929
16.

Genetics of antipsychotic-induced side effects and agranulocytosis.

Chowdhury NI, Remington G, Kennedy JL.

Curr Psychiatry Rep. 2011 Apr;13(2):156-65. doi: 10.1007/s11920-011-0185-3. Review.

PMID:
21336863
17.

Genetic determinants of clozapine-induced agranulocytosis: recent results of HLA subtyping in a non-jewish caucasian sample.

Dettling M, Cascorbi I, Roots I, Mueller-Oerlinghausen B.

Arch Gen Psychiatry. 2001 Jan;58(1):93-4. No abstract available.

PMID:
11146763
18.

Human leukocyte antigen typing, response to neuroleptics, and clozapine-induced agranulocytosis in jewish Israeli schizophrenic patients.

Meged S, Stein D, Sitrota P, Melamed Y, Elizur A, Shmuelian I, Gazit E.

Int Clin Psychopharmacol. 1999 Sep;14(5):305-12.

PMID:
10529073
19.

Association between clozapine-induced agranulocytosis and HLA subtyping.

Lopez-Garcia P, Teresa Rodriguez J, De Castro P, Landecho I, Zapata R.

J Clin Psychiatry. 2006 Oct;67(10):1652-3. No abstract available.

PMID:
17107265
20.

Relation of the Allelic Variants of Multidrug Resistance Gene to Agranulocytosis Associated With Clozapine.

Anıl Yağcioğlu AE, Yoca G, Ayhan Y, Karaca RÖ, Çevik L, Müderrisoğlu A, Göktaş MT, Eni N, Yazıcı MK, Bozkurt A, Babaoğlu MO; Clozapine-Associated LeukopeniaAgranulocytosis Study Group.

J Clin Psychopharmacol. 2016 Jun;36(3):257-61. doi: 10.1097/JCP.0000000000000495.

PMID:
27043126

Supplemental Content

Support Center